Cargando…

Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent

This work aimed to synthesize safe antihyperglycemic derivatives bearing thiazolidinedione fragment based on spectral data. The DFT theory discussed the frontier molecular orbitals (FMOs), chemical reactivity of compounds, and molecular electrostatic potential (MEP) to explain interaction between th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sameeh, Manal Y., Khowdiary, Manal M., Nassar, Hisham S., Abdelall, Mahmoud M., Alderhami, Suliman A., Elhenawy, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773338/
https://www.ncbi.nlm.nih.gov/pubmed/35052707
http://dx.doi.org/10.3390/biomedicines10010024
_version_ 1784636059888386048
author Sameeh, Manal Y.
Khowdiary, Manal M.
Nassar, Hisham S.
Abdelall, Mahmoud M.
Alderhami, Suliman A.
Elhenawy, Ahmed A.
author_facet Sameeh, Manal Y.
Khowdiary, Manal M.
Nassar, Hisham S.
Abdelall, Mahmoud M.
Alderhami, Suliman A.
Elhenawy, Ahmed A.
author_sort Sameeh, Manal Y.
collection PubMed
description This work aimed to synthesize safe antihyperglycemic derivatives bearing thiazolidinedione fragment based on spectral data. The DFT theory discussed the frontier molecular orbitals (FMOs), chemical reactivity of compounds, and molecular electrostatic potential (MEP) to explain interaction between thiazolidinediones and the biological receptor. α-amylase is known as the initiator-hydrolysis of the of polysaccharides; therefore, developing α-amylase inhibitors can open the way for a potential diabetes mellitus drug. The molecular docking simulation was performed into the active site of PPAR-γ and α-amylase. We evaluated in vitro α-amylase’s potency and radical scavenging ability. The compound 6 has the highest potency against α-amylase and radical scavenging compared to the reference drug and other members. They have been applied against anti-diabetic and anti-hyperlipidemic activity (in vivo) based on an alloxan-induced diabetic rat model during a 30-day treatment protocol. The most potent anti hyperglycemic members are 6 and 11 with reduction percentage of blood glucose level by 69.55% and 66.95%, respectively; compared with the normal control. Other members exhibited moderate to low anti-diabetic potency. All compounds showed a normal value against the tested biochemical parameters (CH, LDL, and HDL). The ADMET profile showed good oral bioavailability without any observed carcinogenesis effect.
format Online
Article
Text
id pubmed-8773338
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87733382022-01-21 Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent Sameeh, Manal Y. Khowdiary, Manal M. Nassar, Hisham S. Abdelall, Mahmoud M. Alderhami, Suliman A. Elhenawy, Ahmed A. Biomedicines Article This work aimed to synthesize safe antihyperglycemic derivatives bearing thiazolidinedione fragment based on spectral data. The DFT theory discussed the frontier molecular orbitals (FMOs), chemical reactivity of compounds, and molecular electrostatic potential (MEP) to explain interaction between thiazolidinediones and the biological receptor. α-amylase is known as the initiator-hydrolysis of the of polysaccharides; therefore, developing α-amylase inhibitors can open the way for a potential diabetes mellitus drug. The molecular docking simulation was performed into the active site of PPAR-γ and α-amylase. We evaluated in vitro α-amylase’s potency and radical scavenging ability. The compound 6 has the highest potency against α-amylase and radical scavenging compared to the reference drug and other members. They have been applied against anti-diabetic and anti-hyperlipidemic activity (in vivo) based on an alloxan-induced diabetic rat model during a 30-day treatment protocol. The most potent anti hyperglycemic members are 6 and 11 with reduction percentage of blood glucose level by 69.55% and 66.95%, respectively; compared with the normal control. Other members exhibited moderate to low anti-diabetic potency. All compounds showed a normal value against the tested biochemical parameters (CH, LDL, and HDL). The ADMET profile showed good oral bioavailability without any observed carcinogenesis effect. MDPI 2021-12-23 /pmc/articles/PMC8773338/ /pubmed/35052707 http://dx.doi.org/10.3390/biomedicines10010024 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sameeh, Manal Y.
Khowdiary, Manal M.
Nassar, Hisham S.
Abdelall, Mahmoud M.
Alderhami, Suliman A.
Elhenawy, Ahmed A.
Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
title Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
title_full Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
title_fullStr Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
title_full_unstemmed Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
title_short Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
title_sort discovery potent of thiazolidinedione derivatives as antioxidant, α-amylase inhibitor, and antidiabetic agent
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773338/
https://www.ncbi.nlm.nih.gov/pubmed/35052707
http://dx.doi.org/10.3390/biomedicines10010024
work_keys_str_mv AT sameehmanaly discoverypotentofthiazolidinedionederivativesasantioxidantaamylaseinhibitorandantidiabeticagent
AT khowdiarymanalm discoverypotentofthiazolidinedionederivativesasantioxidantaamylaseinhibitorandantidiabeticagent
AT nassarhishams discoverypotentofthiazolidinedionederivativesasantioxidantaamylaseinhibitorandantidiabeticagent
AT abdelallmahmoudm discoverypotentofthiazolidinedionederivativesasantioxidantaamylaseinhibitorandantidiabeticagent
AT alderhamisulimana discoverypotentofthiazolidinedionederivativesasantioxidantaamylaseinhibitorandantidiabeticagent
AT elhenawyahmeda discoverypotentofthiazolidinedionederivativesasantioxidantaamylaseinhibitorandantidiabeticagent